Short-term peripheral venous catheters (PVCs) are commonly used in healthcare settings. To determine the magnitude of bloodstream infections (BSIs) related to their use, PubMed, article bibliographies, and the authors' library were searched for pertinent articles. The incidence of PVC-related BSIs was 0.18% among 85063 PVCs. Short-term PVCs accounted for a mean of 6.3% and 23% of nosocomial BSIs and nosocomial catheter-related BSIs, respectively. Prolonged dwell time and catheter insertion under emergent conditions increased risk of PVC-related bloodstream infection (PVCR-BSI). If approximately 200 million PVCs are successfully inserted into adult patients each year in the United States, there may be many PVCR-BSIs occurring yearly. Clinicians should obtain blood cultures in patients with evidence of PVC infection and systemic symptomatology such as fever, carefully inspect the PVC insertion site in bacteremic or fungemic patients, and remove PVCs associated with localized infection with or without associated BSI.
Short-term peripheral venous catheters (PVCs) are some of the most commonly utilized medical devices in healthcare settings. Approximately 330 million PVCs are purchased each year in the United States [1] . A prevalence survey in France found that 23% of 330 339 patients hospitalized had a PVC, accounting for 80% (ie, 68 773 PVC) of all intravascular catheters [2] . A prevalence survey in Scotland found that 30% of inpatients in acute care hospitals had a PVC, accounting for 90% of all intravascular catheters [3] . A survey in Spanish hospitals found that 95% of intravascular catheters were PVCs [4] . PVC-related bloodstream infection (PVCR-BSI) can reflect colonization of various sources, whereby microbes can migrate distally along extraluminal and/or intraluminal routes to enter the bloodstream [5, 6] . Phlebitis related to PVCs can be from a chemical, mechanical, or infectious etiology [1, 7, 8] . Most cases of phlebitis from PVCs are unrelated to infection [6, 9, 10] . However, the strongest independent predictor of severe PVC-related phlebitis is catheter colonization [6] , and most patients with PVCR-BSI have phlebitis [7] . Interestingly, even culture-negative ex vivo PVCs frequently have extraluminal and intraluminal colonization as detected by molecular methods [11] . As one of the most authoritative reviews on PVC infections was published >40 years ago [7] , the intent of this article is to provide an update regarding the incidence of bloodstream infections (BSIs) associated with these devices, to compare that risk with such infections due to central venous catheters (CVCs), and to help clarify the impact of PVC dwell time on the risk of PVC colonization and PVCR-BSI.
METHODS
The Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines were followed [12] . PubMed was used to search for articles published from 1 January 1980 through 1 January 2017 using the combined search terms "Staphylococcus aureus bacteremia" AND "peripheral intravenous catheter, " as well as "peripheral intravenous catheter" AND "bacteremia" (Figure 1 ). Articles were also found by reviewing bibliographies from the above search. Last, articles were searched from the author's file of publications collected over the last 29 years.
Studies solely involving pediatric patients were excluded, as were studies solely using steel needle PVCs, or studies in home care settings. If articles included data on steel needle and plastic needle PVCs, the data regarding plastic needle PVCs were included. Of the articles reviewed, if the authors included pediatric and adult patients with PVCs and data from the 2 cohorts could be separated, then only the adult data were included. Only short-term PVCs were included; other PVCs such as midline catheters and peripherally inserted CVCs were excluded. The author reviewed Methods sections of all full-text articles assessed for eligibility. If it was unclear if short-term PVCs were separated from long-term PVCs (ie, peripherally inserted CVCs), then the author contacted the corresponding author to clarify this issue (1 instance of this occurrence). If such articles were not written in English, the author used Google translator to translate the text into English (8 instances of this occurrence). If the author was unsure if an international governing body had collected data regarding PVCR-BSIs, the author contacted an official from that international governing body (1 instance of this occurrence).
RESULTS

Risk of Peripheral Venous Catheter-Related Bloodstream Infection
A previously published literature review revealed the incidence of PVCR-BSI involving 10 910 PVCs was 0.1% or 0.5/1000 catheter-days [13] . In the present review, the incidence of PVCR-BSIs was 0.18% among 85063 PVCs (range, 0-2.2%; [34] [35] [36] . When the incidence of CVC-related bloodstream infection (CVCR-BSI) was compared to PVCR-BSI at the same institutions during the same time period, the relative risk of CVCR-BSI compared to PVCR-BSI varied from 1.5 to 64 (Table 1) [2, 17, 25, [34] [35] [36] [37] [38] [39] . However, in 1 study, the incidence of catheter-related bloodstream infection (CR-BSI) was 2.5-fold higher for PVCs compared to peripherally inserted CVCs [37] . A mean of 22% (range, 7%-60%) of 7860 nosocomial CR-BSIs were due to PVCs (Table 1) [2, [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] . Peripheral venous catheters and CVCs accounted for a mean of 6.3% (range, 4.8%-19%) and a mean of 23% (range, 13%-33%) of 15 936 nosocomial BSIs, respectively [2, 38, 41, 43, 44] .
Dwell Time and Risk of Peripheral Venous Catheters Colonization and Peripheral Venous Catheter-Related Bloodstream Infection
Some studies assessed the impact of PVC duration on the risk of catheter colonization. One study did not find a significant association whereby 5.7% of PVCs in situ 1-3 days were colonized compared to 9.0% of PVCs in situ >3 days (P = .3) [10] . However, a 1996 study found that a PVC dwell time >3 days was associated with catheter colonization during 1996 (relative risk [RR], 2.11; 95% confidence interval [CI], 1.31-3.41) and during 1999 (RR, 3.16; 95% CI, 1.67-5.99), respectively [31] . In addition, prolonged PVC dwell time has been shown to be an independent risk factor for catheter colonization (RR, 1.75; P < .001) [5] ; similarly, a PVC in situ >3 days has been demonstrated to be an independent risk factor for catheter colonization (odds ratio [OR], 4.74; 95% CI, 2.04-10.99) [29] .
Regarding the risk of PVCR-BSI based on PVC dwell time, there was no difference in dwell time of those with and without a PVCR-BSI in a survey of surgical patients with a PVC [17] . One study [42] noted the mean PVC dwell time in PVCR-BSI cases was 3.9 days (±2.1 days). Two additional studies found that 54% [47] and 60% [39] of PVCR-BSIs occurred in catheters in situ >3 days. One study found that 1, 32, and 31 PVCR-BSIs occurred when dwell times were 1 day, 2-4 days, and >4 days, respectively [40] . Another study noted that of 17 PVCR-BSIs with known duration of catheterization, 2 involved PVCs in situ 1-2 days and 15 cases involved PVCs in situ 3 or more days [34] . A study found that 30 of 45 PVCR-BSI cases (67%) involved PVCs with a dwell time of 4 or more days [31] . Last, PVC dwell time >3 days was independently associated with the pooled risk of local site infection, phlebitis, and CR-BSI (adjusted OR, 188; 95% CI, 23-1169), and this was associated with the risk of PVCR-BSI (adjusted OR, 324; 95% CI, 21-1139) [48] .
Risk of Peripheral Venous Catheter-Related Bloodstream Infection due to Staphylococcus aureus
Not surprisingly, PVCR-BSIs due to S. aureus are significantly more likely to have a metastatic focus of infection compared with PVCR-BSIs due to other pathogens, and they have significantly greater attributable mortality [42] . Additionally, the duration of S. aureus bacteremia is significantly longer when due to an infected PVC compared to cases of non-PVC-related S. aureus bacteremia [49] . A mean of 38% (range, 12%-64%) of S. aureus CR-BSIs were due to infected PVCs (Table 2 ) [46, [50] [51] [52] [53] [54] . A mean of 19% (range, 7.6%-35%) of S. aureus BSIs were due to infected PVCs [46, 50, 52, [54] [55] [56] [57] .
Dwell Time and Risk of Peripheral Venous Catheter-Related Bloodstream Infection due to Staphylococcus aureus
Several studies noted reductions in risk of S. aureus bacteremia after instituting infection prevention initiatives involving limits in PVC dwell time to 3 days [48] . or doing so along with other interventions [46, 52, 55, 57] . Studies have assessed the relationship between PVC dwell time and risk of healthcare-associated S. aureus PVCR-BSI. One study of 137 S. aureus PVCR-BSIs noted that 45% involved PVCs in situ beyond 4 days and that 61% had been inserted by the ambulance service or in the emergency department [56] . Another study found the median dwell time was 3 days and 1 day in cases with and without S. aureus PVCR-BSI, respectively (P < .001) [53] .
DISCUSSION
Based on the above-noted data, there is a 2-to 64-fold greater risk of CR-BSI from a CVC than a PVC. However, if 330 million PVCs are used each year in the United States, we exclude approximately one-fourth used in children (https://ftp.cdc. gov/pub/Health_Statistics/NCHS/NHIS/SHS/2015_SHS_ Table_P-10.pdf), and if approximately 20% of PVC insertion in adults have failed attempts [58] , then of the approximately 200 million adults with PVCs with a 0.18% incidence of PVCR-BSI, then there may be many PVCR-BSIs in the United States each year. A PVC dwell time beyond 3 days independently increases risk of PVC colonization. Thus, it is not surprising that it also independently increases risk of PVCR-BSI in adult patients. The incidence of PVCR-BSI in the cited studies varied, likely reflecting the fact that some publications were prospective clinical trials whereas others were point-prevalence surveys, as well as reflecting different patient populations and variability in insertion, maintenance, and PVC duration policies.
Over the last 2 decades, attention has been focused on risk of infection related to central venous access, leading to national campaigns aimed at reducing such events. However, little attention has been paid to the risk of PVCR-BSIs and their prevention despite the fact that 1 in 3 healthcare-associated S. aureus CR-BSIs are due to PVCs with known attributable morbidity and mortality. Thus, it is hoped that the data presented herein will serve as a wake-up call leading to national and international efforts aimed at implementing preventive strategies known to reduce such risk in future patients [31, 45, 46, 52, 55, 57] and to reduce the variability of practice regarding PVC insertion and maintenance [59] . Pragmatic interventions should be instituted, such as education and compliance monitoring in regard to limiting PVC dwell time to 3 days [52, 55, 57, 60] or 4 days [31, 43, 45, 61] as recommended in 2 national guidelines [62, 63] (but not in another one [64] ); daily assessment of the insertion site [46] ; justification for continued catheterization [31] ; removal of idle catheters [46] ; and replacing PVCs inserted under emergent conditions [43, 57] . It should be noted that interventions demonstrated to reduce the incidence of PVCR-BSI may not reduce the incidence of phlebitis as the latter may be due to chemical or mechanical irritation of the catheterized vein in the absence of infection [45] .
Due to the estimated incidence of PVCR-BSI, clinicians should have a high index of suspicion for the PVC as a source of BSI [62] . The PVC insertion site should be inspected daily for evidence of localized infection, or any time a patient develops symptoms suggestive of such an infection. Phlebitis may or may not be infectious in etiology but should prompt catheter removal. Any insertion site exudate should lead to catheter removal and culture of the exudate. Clinicians should obtain blood cultures in patients with findings suggestive of localized PVC infection and systemic symptomatology (eg, otherwise unexplained fever). On the other hand, patients with seemingly enigmatic bacteremia or fungemia should have the PVC insertion site inspected for signs of localized infection, as evidence of localized PVC infection is often overlooked in cases of PVCR-BSI [49] .
Potential limitations of this work reflect the fact that some cited studies were carried out several years ago and risk of PVCR-BSI may have changed during this time. Reporting bias may have limited access to data, reflecting a higher risk of PVC infection. Finally, the articles reviewed focused on adult patients; therefore, the findings may not be relevant to pediatric patients.
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